VASCULAR BIOGENICS LTD's ticker is and the CUSIP is M96883959. A total of 3 filers reported holding VASCULAR BIOGENICS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17 | -99.9% | 100 | -99.3% | 0.00% | – |
| Q2 2022 | $24,000 | +200.0% | 15,000 | +248.8% | 0.00% | – |
| Q4 2021 | $8,000 | -42.9% | 4,300 | -36.8% | 0.00% | – |
| Q3 2021 | $14,000 | -66.7% | 6,800 | -61.6% | 0.00% | – |
| Q2 2021 | $42,000 | +2000.0% | 17,700 | +1866.7% | 0.00% | – |
| Q1 2021 | $2,000 | -71.4% | 900 | -83.9% | 0.00% | – |
| Q4 2019 | $7,000 | -12.5% | 5,600 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | 0.0% | 5,600 | +3.7% | 0.00% | – |
| Q1 2019 | $8,000 | -11.1% | 5,400 | -42.6% | 0.00% | – |
| Q4 2018 | $9,000 | -65.4% | 9,400 | -41.2% | 0.00% | – |
| Q3 2018 | $26,000 | -78.5% | 16,000 | -70.9% | 0.00% | -100.0% |
| Q2 2018 | $121,000 | -51.4% | 55,000 | -49.2% | 0.00% | -66.7% |
| Q1 2018 | $249,000 | +141.7% | 108,200 | +646.2% | 0.00% | +200.0% |
| Q4 2017 | $103,000 | +1616.7% | 14,500 | +1350.0% | 0.00% | – |
| Q3 2017 | $6,000 | -80.0% | 1,000 | -81.8% | 0.00% | – |
| Q1 2017 | $30,000 | -50.8% | 5,500 | -56.0% | 0.00% | -100.0% |
| Q4 2016 | $61,000 | +281.2% | 12,500 | +316.7% | 0.00% | – |
| Q3 2016 | $16,000 | -66.7% | 3,000 | -71.2% | 0.00% | -100.0% |
| Q2 2016 | $48,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 492 | $117,000 | 0.02% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 17,700 | $42,000 | 0.00% |
| SIMPLEX TRADING, LLC | 11,400 | $27,000 | 0.00% |